About
Dr. Tiffany Li is an early career researcher affiliated with the School of Medical Sciences at the University of Sydney's Faculty of Medicine and Health, and a member of the Brain and Mind Centre. She holds a PhD (2024) and a Master of Biostatistics (Macquarie University). Her research focuses on chemotherapy-induced peripheral neuropathy, including biomarker identification, risk factors, and outcome measures.
Key research interests include cancer survivorship, clinimetric analysis, neurophysiology, and chemotherapy toxicity. She has received notable awards such as the 2024 Brain and Mind Centre Emerging Researcher Award and the Jonathon Pembroke Award. Her work spans clinical trials, systematic reviews, and translational studies.
Recent grants include funding from the American Academy of Neurology, the Neil and Norma Hill Foundation, and the Faculty of Medicine and Health. Collaborations emphasize international research networks and interdisciplinary approaches to neurotoxicity assessment.
